The NLRC4 (NLR Family CARD Domain Containing 4) gene encodes a critical pattern recognition receptor that forms the NLRC4 inflammasome, a multiprotein complex essential for innate immunity and inflammatory responses. While primarily studied in the context of bacterial infection, emerging research reveals important roles for NLRC4 in neuroinflammation and neurodegenerative diseases[1].
NLRC4 (also known as IPAF - ICE protease-activating factor) is a member of the NLR (NOD-like receptor) family of proteins. Unlike NLRP3 which responds to diverse stressors, NLRC4 has specialized recognition capabilities for bacterial pathogen-associated molecular patterns (PAMPs), particularly flagellin from flagellated bacteria and components of the type III secretion system (T3SS)[2].
NLRC4 contains several functional domains:
The NACHT domain undergoes conformational changes upon ATP binding, enabling NLRC4 oligomerization into a wheel-like structure that serves as a platform for caspase-1 activation[3].
NLRC4 forms inflammasomes in response to bacterial flagellin or T3SS rod proteins:
The NLRC4 inflammasome activates multiple downstream pathways:
NLRC4 inflammasome activation contributes to chronic neuroinflammation in AD:
In PD, NLRC4 plays complex roles:
NLRC4 in ALS:
While not directly neurodegenerative, NLRC4 mutations cause early-onset enterocolitis (NLRC4-related autoinflammatory disease, NLRC4-AD), demonstrating the critical role of this inflammasome in human health[7].
NLRC4 expression patterns:
In the brain:
NLRC4 represents a promising therapeutic target:
Small molecule inhibitors:
Therapeutic strategies:
Combination approaches:
The study of Nlrc4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Broz P, Dixit VM. (2016). Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 16(7):407-420. https://pubmed.ncbi.nlm.nih.gov/27291964/ ↩︎
Vance RE. (2015). The NAIP/NLRC4 inflammasomes. Curr Opin Immunol. 32:84-89. https://pubmed.ncbi.nlm.nih.gov/25950453/ ↩︎
Hu Z, et al. (2015). Structural and biochemical basis for induced self-propagation of NLRC4. Science. 350(6262):404-409. https://pubmed.ncbi.nlm.nih.gov/26449475/ ↩︎
Heneka MT, et al. (2013). NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature. 493(7433):674-678. https://pubmed.ncbi.nlm.nih.gov/23254930/ ↩︎
Sun L, et al. (2020). NLRC4 inflammasome contributes to dopaminergic neuronal death via promoting neuroinflammation in Parkinson's disease models. J Neuroinflammation. 17(1):258. https://pubmed.ncbi.nlm.nih.gov/32791956/ ↩︎
Debye B, et al. (2019). Inflammasome activation in amyotrophic lateral sclerosis. Acta Neuropathol. 138(3):363-378. https://pubmed.ncbi.nlm.nih.gov/31115772/ ↩︎
Canna SW, et al. (2014). An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 46(10):1140-1146. https://pubmed.ncbi.nlm.nih.gov/25217959/ ↩︎